Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
La Jolla Pharmaceutical (NASDAQ:LJPC) reported its Q1 earnings results on Monday, May 16, 2022 at 04:15 PM.
Here's what investors need to know about the announcement.
La Jolla Pharmaceutical missed estimated earnings by 100.0%, reporting an EPS of $0.0 versus an estimate of $0.01.
Revenue was down $23.71 million from the same period last year.
Last quarter the company beat on EPS by $0.07 which was followed by a 1.15% drop in the share price the next day.
To track all earnings releases for La Jolla Pharmaceutical visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: LJPC